We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,497
Closed
1,027

Top Buys

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$74.4M
2
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$42.5M
3
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$24.2M
4
SMH icon
VanEck Semiconductor ETF
SMH
+$17.4M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$12.9M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$105M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.8M
4
MSFT icon
Microsoft
MSFT
+$12.8M
5
AAPL icon
Apple
AAPL
+$11.9M

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGO
4476
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$0 ﹤0.01%
4
-625
-99% -$45.8K
CCF
4477
DELISTED
Chase Corporation
CCF
$0 ﹤0.01%
+3
New +$297
APRN
4478
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$0 ﹤0.01%
3
-8
-73% -$1.16K
NXGN
4479
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
– –
-18
Closed –
ICPT
4480
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-162
Closed -$18K
AVID
4481
DELISTED
Avid Technology Inc
AVID
– –
-355
Closed -$3K
JPT
4482
DELISTED
Nuveen Preferred and Income Fund
JPT
$0 ﹤0.01%
+6
New +$141
BRQS
4483
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
– –
0
– –
EMAN
4484
DELISTED
eMagin Corporation
EMAN
$0 ﹤0.01%
80
– –
RAD
4485
DELISTED
Rite Aid Corporation
RAD
– –
-5,959
Closed -$76K
MMP
4486
DELISTED
Magellan Midstream Partners, L.P.
MMP
– –
-3,885
Closed -$236K
INFI
4487
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-2,703
Closed -$5K
HARP
4488
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-6
Closed -$1K
DMS
4489
DELISTED
Digital Media Solutions, Inc.
DMS
– –
-60
Closed -$9K
AMRS
4490
DELISTED
Amyris Inc.
AMRS
– –
-11,575
Closed -$24K
SAL
4491
DELISTED
Salisbury Bancorp, Inc.
SAL
– –
-272
Closed -$6K
ARDS
4492
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$0 ﹤0.01%
+38
New +$366
MLVF
4493
DELISTED
Malvern Bancorp, Inc.
MLVF
– –
-895
Closed -$18K
ISEE
4494
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-500
Closed -$1K
IMBI
4495
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$0 ﹤0.01%
20
– –
USX
4496
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
– –
-2,142
Closed -$14K
BNSO
4497
DELISTED
Bonso Electronic International
BNSO
– –
-100
Closed –
ACOR
4498
DELISTED
Acorda Therapeutics
ACOR
– –
-13
Closed -$20K
MNTV
4499
DELISTED
Momentive Global Inc. Common Stock
MNTV
– –
-12
Closed –
CYAD
4500
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$0 ﹤0.01%
1
-39
-98% -$744
178 179
180
181 182

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,027 positions and reducing 1,497 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,027 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.